Moorfields Eye Hospital, London, UK.
University College London, London, UK.
Diabet Med. 2019 Apr;36(4):424-433. doi: 10.1111/dme.13868. Epub 2018 Dec 7.
Diabetic retinopathy is a common microvascular complication of diabetes and remains one of the leading causes of preventable blindness in working-age people. Non-proliferative diabetic retinopathy is the earliest stage of diabetic retinopathy and is typically asymptomatic. Currently, the severity of diabetic retinopathy is assessed using semi-quantitative grading systems based on the presence or absence of retinal lesions. These methods are well validated, but do not predict those at high risk of rapid progression to sight-threatening diabetic retinopathy; therefore, new approaches for identifying these people are a current unmet need. We evaluated published data reporting the lesion characteristics associated with different progression profiles in people with non-proliferative diabetic retinopathy. Based on these findings, we propose that additional assessments of features of non-proliferative diabetic retinopathy lesions may help to stratify people based on the likelihood of rapid progression. In addition to the current classification, the following measurements should be considered: the shape and size of lesions; whether lesions are angiogenic in origin; the location of lesions, including predominantly peripheral lesions; and lesion turnover and dynamics. For lesions commonly seen in hypertensive retinopathy, a detailed assessment of potential concomitant diseases is also recommended. We believe that natural history studies of these changes will help characterize these non-proliferative diabetic retinopathy progression profiles and advance our understanding of the pathogenesis of diabetic retinopathy in order to individualize management of people with diabetic retinopathy.
糖尿病性视网膜病变是糖尿病常见的微血管并发症,也是工作年龄段人群可预防盲的主要原因之一。非增生性糖尿病性视网膜病变是糖尿病性视网膜病变的最早阶段,通常无症状。目前,糖尿病性视网膜病变的严重程度是通过基于视网膜病变存在与否的半定量分级系统来评估的。这些方法经过了很好的验证,但并不能预测那些有快速进展为威胁视力的糖尿病性视网膜病变风险高的患者;因此,目前需要寻找新的方法来识别这些人。我们评估了报告与非增生性糖尿病性视网膜病变患者不同进展特征相关的病变特征的已发表数据。基于这些发现,我们提出对非增生性糖尿病性视网膜病变病变的特征进行额外评估可能有助于根据快速进展的可能性对患者进行分层。除了目前的分类,还应考虑以下测量:病变的形状和大小;病变是否源于血管生成;病变的位置,包括主要是周边病变;以及病变的更替和动态。对于常见于高血压性视网膜病变的病变,还建议对潜在的伴随疾病进行详细评估。我们相信,对这些变化的自然史研究将有助于描述这些非增生性糖尿病性视网膜病变的进展特征,并深入了解糖尿病性视网膜病变的发病机制,从而实现对糖尿病性视网膜病变患者的个体化管理。